RECRUITING
I'm interested ...!!
Understanding Chronic Lymphocytic Leukemia
The purpose of this study is to collect human Chronic Lymphocytic Leukemia tissue samples and medical information, in order to find out more about the causes and biology of chronic lymphocytic leukemia.
Conditions:
🦠 Chronic Lymphocytic Leukemia
🗓️ Study Start (Actual) 29 September 1999
🗓️ Primary Completion (Estimated) 29 September 2024
✅ Study Completion (Estimated) 29 September 2026
👥 Enrollment (Estimated) 2750
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Boston, Massachusetts, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * New and existing patients seen for treatment of monoclonal B-cell lymphocytosis
    • * Any low grade lymphoproliferative disorder
    • * Chronic Lymphocytic Leukemia in the Dana Farber Cancer Institute Hematologic Oncology Clinic or elsewhere

    Exclusion Criteria:

    • -
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 26 June 2019
  • First Submitted that Met QC Criteria 19 July 2019
  • First Posted 22 July 2019

Study Record Updates

  • Last Update Submitted that Met QC Criteria 4 March 2024
  • Last Update Posted 5 March 2024
  • Last Verified March 2024
I'm interested ...!!